Peanut oral immunotherapy increases IgG4 to Ara h 1, 2, and 6 but does not affect IgG4 to other allergens

Pediatr Allergy Immunol. 2019 Mar;30(2):248-252. doi: 10.1111/pai.13012. Epub 2019 Jan 31.

Authors

Riikka Uotila¹, Anna Kaarina Kukkonen¹, Dario Greco^{2

3}, Anna Susanna Pelkonen¹, Mika Juhani Mäkelä¹

Affiliations

¹ Department of Allergology, the Skin and Allergy Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
² Faculty of Medicine and Life Sciences, Institute of Biosciences and Medical Technologies (BioMediTech), University of Tampere, Tampere, Finland.
³ Institute of Biotechnology, University of Helsinki, Helsinki, Finland.

PMID: 30561805
DOI: 10.1111/pai.13012

No abstract available

Keywords: IgG4; Immuno-Solid phase Allergen Chip; cross-reactivity; immunotherapy; peanut allergens.

Publication types

Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Allergens / immunology*
Antigens, Plant / immunology
Arachis / immunology*
Child
Double-Blind Method
Female
Humans
Immunoglobulin G / blood*
Immunotherapy / methods*
Male
Peanut Hypersensitivity / therapy*

Substances

Allergens
Antigens, Plant
Immunoglobulin G

Grants and funding